Results From the REsCue Trial: A Randomized Controlled Trial with Extended-Release Calcifediol in Symptomatic Outpatients with COVID-19

Charles W. Bishop, Akhtar Ashfaq, Joel Z. Melnick, Enrique Vazquez-Escarpanter, Jonathan A. Fialkow, Stephen A. Strugnell, John Choe, Kamyar Kalantar-Zadeh, Noah C. Federman, David Ng, John S. Adams
doi: https://doi.org/10.1101/2022.01.31.22270036

Article usage

Article usage: February 2022 to September 2023

AbstractFullPdf
Feb 2022248674478
Mar 202231722107
Apr 2022206454
May 2022201665
Jun 2022184635
Jul 2022134127
Aug 2022142526
Sep 2022121118
Oct 202279120
Nov 202289315
Dec 202284139
Jan 202350215
Feb 202366315
Mar 202337518
Apr 202341314
May 202335110
Jun 202326414
Jul 202323215
Aug 2023521025
Sep 202330616
Back to top
Posted February 05, 2022.
Download PDF
Data/Code
Email
Results From the REsCue Trial: A Randomized Controlled Trial with Extended-Release Calcifediol in Symptomatic Outpatients with COVID-19
Charles W. Bishop, Akhtar Ashfaq, Joel Z. Melnick, Enrique Vazquez-Escarpanter, Jonathan A. Fialkow, Stephen A. Strugnell, John Choe, Kamyar Kalantar-Zadeh, Noah C. Federman, David Ng, John S. Adams
medRxiv 2022.01.31.22270036; doi: https://doi.org/10.1101/2022.01.31.22270036
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area